The Best CBD Cream for Knee Pain: What the Science Actually Says

Knee pain is one of the most common musculoskeletal complaints in the United States. According to the Cleveland Clinic, roughly 25% of adults experience frequent knee pain that limits function and reduces quality of life. Whether caused by osteoarthritis, ligament injuries, overuse, or the natural effects of aging, knee pain can transform everyday activities like walking, climbing stairs, and exercising into a source of dread.

For decades, the standard approach has been a familiar cycle: NSAIDs, corticosteroid injections, physical therapy, and — when those fail — surgical intervention. But a growing body of research suggests that topical cannabidiol (CBD) may offer a compelling, plant-based alternative for managing knee pain and the inflammation that drives it.

In this science-based guide, we explore how CBD interacts with the body’s endocannabinoid system to modulate pain and inflammation in the knee joint, what peer-reviewed research has found, and how Entourus CBD + Terpenes formulations are engineered to deliver targeted relief.

Understanding Knee Pain: Why the Joint Is So Vulnerable

The knee is the largest and one of the most mechanically complex joints in the human body. It bears the full weight of the torso during standing, walking, running, and jumping — absorbing forces of up to six times body weight during activities like stair descent. This makes the knee uniquely vulnerable to both acute injury and chronic degenerative disease.

Osteoarthritis (OA) is the leading cause of chronic knee pain, affecting more than 32.5 million adults in the United States according to the CDC. In knee OA, the cartilage that cushions the joint gradually breaks down, leading to bone-on-bone friction, chronic inflammation, synovial thickening, and progressive pain. Inflammatory cytokines — including tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) — play a central role in both cartilage degradation and pain signaling in the osteoarthritic knee.

How CBD Works: The Endocannabinoid System and Joint Pain

The endocannabinoid system (ECS) is a complex cell-signaling network found throughout the human body, including in joint tissues, synovial fluid, and surrounding muscle and connective tissue. The ECS is composed of endocannabinoids (naturally produced compounds), cannabinoid receptors (CB1 and CB2), and enzymes that synthesize and break down endocannabinoids.

CB1 receptors are concentrated in the central nervous system and play a key role in modulating pain perception. CB2 receptors are primarily expressed on immune cells and in peripheral tissues — including the synovial membrane of joints — where they help regulate inflammatory responses. A landmark review confirmed that cannabinoids suppress nociceptive (pain) processing through activation of both CB1 and CB2 receptor subtypes.

CBD does not bind directly to cannabinoid receptors in the way THC does. Instead, it inhibits the enzyme fatty acid amide hydrolase (FAAH), which is responsible for breaking down the endocannabinoid anandamide. By slowing this breakdown, CBD effectively increases the concentration of anandamide at CB1 and CB2 receptor sites — amplifying the body’s own pain-modulating mechanisms. CBD has also been shown to attenuate the NF-κB inflammatory signaling pathway, reducing the production of the very cytokines (TNF-α, IL-1β, IL-6) that drive knee OA progression.

What the Research Says: Topical CBD and Knee Pain

A growing number of peer-reviewed studies have examined the effects of CBD on arthritis-related pain. In a widely cited 2016 preclinical study published in the European Journal of Pain, researchers applied transdermal CBD gel to rats with adjuvant-induced arthritis and found that it significantly reduced joint swelling, limb posture scores (a measure of spontaneous pain), immune cell infiltration, and synovial membrane thickening — all in a dose-dependent manner, with no evident side effects.

In 2024, a human feasibility trial published in Scientific Reports examined transdermal CBD gel (4% w/w) applied three times daily by patients with hand osteoarthritis over four weeks. Participants experienced statistically significant reductions in current pain, average pain, and maximum pain from baseline. While this trial focused on hand OA, the mechanisms of action are directly transferable to knee OA, as both involve the same inflammatory pathways and ECS receptor activity.

A randomized controlled trial published in the Journal of Hand Surgery found that topical CBD treatment produced significant improvements in pain and disability for thumb basal joint arthritis without adverse events. And an exploratory cross-sectional study published in the Journal of Cannabis Research reported a 44% average reduction in pain among arthritis patients using CBD, with the osteoarthritis cohort showing the greatest improvement.

Meanwhile, research published in Pain demonstrated that early CBD intervention in a rat model of osteoarthritis attenuated both inflammation and pain-related nerve damage, suggesting CBD may have preventive as well as therapeutic potential for joint disease.

Why Topicals? The Case for Transdermal CBD Delivery

Topical CBD creams, salves, and gels offer a distinct advantage for localized joint pain: they deliver cannabidiol directly to the tissues where it is needed most. Unlike oral CBD — which must pass through the digestive system and liver (first-pass metabolism) before reaching systemic circulation — topical formulations bypass this process entirely, concentrating active compounds in the target area.

Research has confirmed that CBD can successfully permeate human skin and reach underlying tissues, particularly when formulated with appropriate vehicles and permeation enhancers. The lipophilic (fat-soluble) nature of CBD allows it to accumulate in the skin and subcutaneous tissue, creating a local depot of anti-inflammatory and analgesic activity around the knee joint.

The Terpene Advantage: Why Entourus Goes Beyond CBD Alone

At Entourus, we formulate our topicals with carefully selected terpene blends because research consistently demonstrates that CBD works better when it is not working alone. This principle — known as the entourage effect — describes the synergistic interaction between cannabinoids, terpenes, and other plant compounds that amplifies therapeutic outcomes beyond what any single molecule can achieve.

Several terpenes are particularly relevant to knee pain and joint inflammation:

Entourus Soothe Salve + and Synergy Salve + are formulated with key terpene profiles in mind — delivering a multi-pathway approach to knee pain that addresses inflammation, nociception, and the underlying endocannabinoid imbalances that perpetuate chronic joint discomfort.